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In Vitro Activities Against Clinical Isolates of Staphylococ-
cus aureus
A. Koteli ∗, A. Kakoulidou, S. Tsingene, M. Andronoglou
‘G. Gennimatas’ Thessaloniki General Hospital, Thessa-
loniki, Greece
Objectives: The objective of this study was to evaluate
and compare the in vitro activity against clinical isolates
of Staphylococcus aureus from varius species in a general
Hospital over a period of four years. Staphylococcus aureus
ATCC 29213 was used as quality control strains.
Methods: A total 3139 positive cultures between
2004—2005 and 3311 between 2006—2007 were tested. 107
strains between 2004—2005 and 121 between 2006—2007
were identiﬁed as Staphylococcus aureus. All specimens
were routinely inoculated into culture media. The blood
cultures were incubated in Bactec 9120 system (Becton Dick-
inson) for 7 days and in aerobic plus, anaerobic plus and
mycosis vials. Identiﬁcation of microorganisms and suscep-
tibility test was performed out with the Vitek 1 (BioMerieux,
France) for 2004—2005 and the Vitek 2 for 2006—2007 and
the susceptibility disc diffusion method according to CLSI
directions. Control of resistance to oxacillin was accom-
plished with oxacillin disk 1mg on Muller Hinton agar with
the addition of NaCl 4% and was conﬁrmed with the detec-
tion of PBP2a of MRSA (Slidex MRSA - BioMerieux). In
order to conﬁrm this we used the nutritious material BBLTM
CHROMagarTM MRSA of Becton Dickinson for 2006—2007. In
order to examine the production of b-lactamase we used
ceﬁnase discs (ceﬁnaseTM CEF-F) BioMerieux, France.
Results: The resistance rates (%) for 2004—2005 and
2006—2007 were: oxacillin 48/52, erythromycin 55/36,
rifampicin 14/6, ciproﬂoxacin 17/19, gentamycin 41/84,
clindamycin 17/20, tetracycline 39/44, linezolid 0/0, lev-
oﬂoxacin 10/12, quinopristin/dulfopristin 0/1, teicoplanin
8/0, vancomycin 8/0.
Conclusion: The resistance rates of Staphylococcus
aureus are very high although there is a small reduction of
the number of isolates in the last two years. The resistance
of Staphylococcus aureus to the antibiotics used appears to
vary during the four years of this study.
doi:10.1016/j.ijid.2008.05.732
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Linezolid Resistance Among Enterococci Correlates to the
Number of 23S G2576t Mutations and Duration of Therapy
I. Spiliopoulou1, V. Chini 1, F. Kolonitsiou1, E.D.
Anastassiou1,∗, E. Petinaki 2
1 University of Patras, Patras, Greece
2 University of Thessalia, Larissa, Greece
Background: Resistance to linezolid among enterococci
is associated with mutation G2576T in the domain V of 23S
rDNA, generating a new NheI restriction site. Duration of
linezolid treatment affects the emergence and the num-
ber of mutated 23S rDNA genes in enterococci, enhancing
persistence and spread of such resistant strains.
Methods: Fourteen linezolid-resistant and ﬁve suscep-
tible clinical isolates recovered from patients hospitalized
in ICUs of different hospitals were studied. Strain clonality
was analyzed by PFGE of SmaI DNA digests. Chromosomal
DNA was isolated and PCR of a 420 bp part in the V domain
of the 23S rRNA gene was performed. PCR products were
sequenced. Combination of EcoRI/NheI DNA digests coupled
with hybridization of a speciﬁc-domain V rDNA probe was
used and results were interpreted with respect to MIC lev-
els to linezolid, duration of treatment, and PFGE patterns
of strains. The number of hybridization bands digested with
EcoRI/NheI representing the number of mutated genes, as
compared to EcoRI alone representing the total number of
23S rDNA genes, was evaluated.
Results: Linezolid-resistant strains carried G2576T muta-
tion(s). The ratio of mutated alleles versus total 23S
rDNA genes was correlated with linezolid resistance lev-
els and duration of therapy. All ﬁve linezolid-sensitive and
eight resistant strains were isolated from patients with-
out prior antibiotic therapy, while six resistant strains
were recovered from patients under linezolid treatment.
Spread of the same resistant clones among patients without
prior linezolid exposure as those recovered from patients
treated with the speciﬁc agent was detected. Strains
carrying different number of mutated genes belonged
to the same clone, suggesting that strains with higher
copies of mutated alleles have evolved in the hospital
setting.
Conclusion: Even though duration of linezolid therapy
appears to be critical to development and level of resis-
tance, nosocomial transmission is a fact, underscoring strict
implementation of infection control measures.
doi:10.1016/j.ijid.2008.05.733
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Methicillin-Resistant Staphylococcus aureus (MRSA) and
MLSB (Macrolide-Lincosamide-Stretogramin B) Isolated
from Community and Hospital - Associated Infections
(Ca/Ha-MRSA)
L.M. Junie1,∗, D. Homorodean2
1 University of Medicine and Pharmacy, Cluj Napoca, Roma-
nia
2 The Laboratory of ‘Leon Daniello’ Pneumoftiziological
Hospital, Cluj Napoca, Romania
Background: MRSA is associated with an increasing num-
ber of both community and hospital-associated infections
(CA/HA-MRSA). Resistance to the macrolides (MLSB resis-
tance) in staphylococci may be due to an active efﬂux
mechanism (encoded by the mrsA gene) or to the modiﬁ-
cation of the ribosomal target (encoded by ermA or ermC
genes). MLSB resistance is either constitutive or inducible
by certain macrolides. Objective: The aim of our study was
to test the resistance of S. aureus strains isolated in Cluj
Napoca.
Method: Identiﬁcation was performed by APY sys-
tem (BioMerieux). The resistance proﬁles were performed
according to NCCLS by disk diffusion and dilution method in
Mueller-Hinton agar supplemented with 2% NaCl (oxacillin)
to Gentamicin, Tobramycin, Lyncomycin, Erythromycin,
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Clindamycin. For inducible MLSB detection has been used
D-zone test according to NCCLS.
Results: 359 S. aureus strains were isolated from sputum
(47%), bronchial lavages (20%), pharyngeal exudates (21%),
pus (9%), others (3%). The isolated strains were MSSA (71%),
MRSA (10%) and MRSA +MLSB (19%). 104 MRSA were isolated;
6% of strains were Erythromycin and Lyncomycin susceptible;
56% Erythromycin resistant, 38% were resistant to MLSB of
which 14% were inducible MLSB and 24% were constitutive
MLSB. Constitutive MLSB resistance was signiﬁcantly higher
than the inducible MLSB resistance (24% and 14%).
Conclusions: Our data suggest that MLSB resistance is
highly prevalent in S. aureus strains and infections caused by
S aureus, especially MRSA and MLSB, continue to be a major
challenge in Romania.
doi:10.1016/j.ijid.2008.05.734
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Molecular Characterization of Antibiotic Resistant Ente-
rococci
H. Helmi, L. Aboulfadl, S. Saad El-Dine, I. El-Defrawy ∗
Theodor Bilharz Research Institute (TBRI), Guiza, Egypt
Infections caused by antibiotic-resistant Enterococci are
increasing and are becoming difﬁcult to manage due to the
diminishing number of available antibiotics to treat them.
This study was conducted to investigate the species preva-
lence, antimicrobial resistance pattern and B-lactamase
production among clinical isolates of Enterococci. The
molecular basis of carriage of resistance genes to high level
aminoglycosides and vancomycin and the genetic related-
ness between the strains were also studied.
A total of 120 isolates of antibiotic resistant Entero-
cocci were investigated. Minimum inhibitory concentrations
(MIC) to high-level aminoglycoside and glycopeptide antibi-
otics were determined by agar dilution and E-test methods
respectively. Genes encoding aminoglycoside modifying
enzymes (AMEs) and vancomycin-resistance determinants
were detected by polymerase chain reaction (PCR). They
were typed by pulsed ﬁeld gel electrophoresis (PFGE).
The clinical isolates of Enterococci were cultured from
urine (70%), wounds (15%), blood (7%), ear (5%) and ﬂu-
ids (3%). They comprised E. faecalis (92.5%), E. faecium
(6.7%) and E. casseliﬂavus (0.8%). None of the Entero-
cocci produced penicillinase but 9.2% were resistant to
ampicillin. Resistance to erythromycin (62.5%), tetracy-
cline (60%), ciproﬂoxacin (40%) and chloramphenicol (28.3%)
were more prevalent. High-level resistance to aminogly-
cosides; amikacin, gentamicin, kanamycin, tobramycin and
streptomycin were detected in 26.7%, 20.8%, 21.6%, 20.8%,
23.3% of the isolates respectively. Most of the high-level
aminoglycoside-resistant isolates contained genes coding
the bifunctional AMEs AAC (6′)-APH (2′′), APH (3′) and ANT
(6′) but not ANT (4′) enzyme. The results demonstrated a low
prevalence of vancomycin resistance (4.2%) among Entero-
cocci. All of them gave positive results for the presence of
the vanA genotype. PFGE revealed heterogenous patterns
with no dominant clone suggesting that the strains acquired
resistance independently.
It is concluded that although the prevalence of glycopep-
tide resistance was low among the studied isolates, its
presence together with high-level aminoglycoside resistance
call for regular surveillance of antibacterial susceptibilities
to detect emerging resistance and prevent the establish-
ment and spread of multiply antibacterial-resistant strains.
doi:10.1016/j.ijid.2008.05.735
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Antimicrobial Resistance and Serotype Distribution of
Streptococcus pneumoniae Isolates Among Children
Under 5 Years of Age, Hai Phong City, Vietnam, July
2006—October 2007
N. Thi Hien Anh1, D. Duc Anh1, N. Cong Khanh1, B.
Nyambat2, P. Kilgore2, V. Thi Thu Huong3,∗, K. Watanabe3,
L.M. Yoshida3, K. Aryioshi 3
1 National Institute of Hygiene and Epidemiology, Hanoi,
Vietnam
2 International Vaccine Institute, Seoul, Republic of Korea
3 Nagasaki University, Nagasaki, Japan
Background: Penicillin resistant and multi-drug resistant
pneumococci are now emerging worldwide. Understanding
antimicrobial resistance patterns and serotype distributions
of pneumococcal isolates from hospitalized children is criti-
cal to provide optimal antimicrobial therapy and understand
the impact of pneumococcal conjugate vaccines.
Methods: We identiﬁed 84 pneumococcal isolates (80
nasopharyngeal swab and 4 invasive specimens) among hos-
pitalized patients at Hai Phong Children’s Hospital, Vietnam
from July 2006 through October 2007. Among the 84 strains,
80 were available for MIC testing and all were serotyped
using standard pneumococcal typing antisera (Statens Serum
Institut, Copenhagen, Denmark).
Results: Seventy-seven percent of strains showed resis-
tance to penicillin (74% intermediate and 3% fully resistant).
Seventy-ﬁve percent of strains showed multi-drug resis-
tance. In addition, 100% of isolates were resistant to
cotrimoxazole, 71% of isolates were resistant to ery-
thromycin and 58% were resistant to cefuroxime. All
isolates were susceptible to amoxicillin, cefotaxime, cef-
triaxone, cefepime, oﬂoxacin and vancomycin. Among the
84 serotypes, 77% (95% CI: 66.7, 85.5) were included in
the 7-valent pneumococcal conjugate vaccine including: 19F
(30%), 23F (21%), 14 (13%) and 6B (13%). Six other serotypes
(13, 15C, 18, 11A, 15B and 6A) accounted for 12% of strains
and 9 (11%) strains were untypeable.
Conclusions: Pneumococcal isolates in the northern
region of Vietnam continue to show substantial drug resis-
tance. These data underscore the value of laboratory-based
surveillance for invasive pneumococcal disease and suggest
that the currently available pneumococcal conjugate vac-
cine could have a substantial impact in reducing the burden
of IPD in Vietnam.
doi:10.1016/j.ijid.2008.05.736
